idiopathic pulmonary fibrosis

HOUSTON, Texas, May 19, 2026 Oorja Bio announced positive first-in-human Phase 1 clinical data for ORJ-001, a first-in-class peptide...

Stockholm, Sweden – April 22, 2026 In a significant advancement for respiratory therapeutics, Vicore Pharma has announced the successful...

MUMBAI, India and WARREN, N.J., April 3, 2026 Cipla USA Inc., a subsidiary of Cipla Limited, has received final...

NEW YORK, April 2, 2026 PureTech Health plc has announced the publication of its Phase 2b ELEVATE IPF trial...

SHANGHAI, Feb. 12, 2026 — AGCO Biomedical Technology Co., Ltd. announced that the U.S. Food and Drug Administration (FDA)...

Stockholm, Sweden, December 19, 2025 — Vicore Pharma Holding AB (publ) announced that it will move from the Nasdaq...